Research Article
Copper-64 Dichloride as Theranostic Agent for Glioblastoma Multiforme: A Preclinical Study
Figure 1
Whole-body mouse biodistribution images collected 1, 2, 4, and 20 hours after intravenous injection of 12 MBq of [64Cu]CuCl2. Increased tracer uptake is observed in the tumor graft (white arrow).